Abstract |
The influence of a once-a-day sustained-release theophylline ( Uniphyl) on lymphocytes and eosinophils in the peripheral blood and sputum of patients with bronchial asthma was investigated. The peripheral blood lymphocytes included CD4, CD8, CD25 and HLA-DR. The sputum lymphocytes and eosinophils included CD4, CD8, CD25 and HLA-DR, and EG2, respectively. The results revealed that theophylline administration did not affect the numbers of activated CD4 and CD8 T lymphocytes in peripheral blood. No significant change in the lymphocyte count was observed in sputum, but the eosinophil count in the sputum decreased significantly after theophylline administration. EG2-positive eosinophils also decreased in number. CD4+HLA-DR+ and CD4+CD25+ T lymphocytes were significantly decreased, whereas CD8+ T lymphocytes in the sputum were not significantly reduced in number. Respiratory function test showed that forced expiratory volume in 1 s was significantly increased after theophylline administration. The results suggest that a new once-a-day sustained-release theophylline formulation would be useful in the treatment of chronic respiratory tract inflammation.
|
Authors | Y Tohda, H Kubo, T Iwanaga, M Fukuoka, S Nakajima |
Journal | The Journal of international medical research
(J Int Med Res)
2001 Nov-Dec
Vol. 29
Issue 6
Pg. 528-36
ISSN: 0300-0605 [Print] England |
PMID | 11803738
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Asthma
(drug therapy)
- Eosinophils
(drug effects, immunology)
- Humans
- Immunophenotyping
- Lymphocyte Activation
(drug effects)
- Lymphocytes
(drug effects, immunology)
- Sputum
(cytology)
- Theophylline
(pharmacology, therapeutic use)
|